News
JNJ
147.52
-0.85%
-1.27
Catalyst Watch: Boeing hearing, Bitcoin halving event and new eyes on Reddit
Seeking Alpha's Catalyst Watch looks at events that may impact stock prices next week. The Bitcoin halving event will be a major focus in the cryptocurrency world. Options trading volume is elevated on electric vehicle stocks Nikola and Rivian. The four-day NAB Show in Las Vegas will focus on cybersecurity and the role of AI in media.
Seeking Alpha · 14h ago
3 Quarterly Releases to Watch Next Week
NASDAQ · 14h ago
55 April Dividend Kings: Buy 8, Watch 8
Seeking Alpha · 14h ago
Short interest in S&P 500 health stocks rises, Moderna among most shorted companies in March
Short percentage in S&P 500’s healthcare companies surged in the end of March from February. Life science tools and services was the most shorted industry in the healthcare sector for March end. Average short interest in s&p 500 health stocks rises to 1.57% in March. Moderna among mostShorted companies in March with 6.42% of float.
Seeking Alpha · 15h ago
Major banks deliver EPS beat this week to kick off Q1 earnings; JPMorgan FY interest margin guidance unchanged - Earnings Scorecard
Major banks deliver EPS beat this week to kick off Q1 earnings; JPMorgan FY interest margin guidance unchanged. Of the 12 companies in the S&P 500 that have reported earnings this quarter, 75% reported EPS above analyst expectations. On Wednesday, Delta Air Lines and Constellation Brands topped estimates.
Seeking Alpha · 16h ago
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper Index for the week of April 12 showcases five stocks that warrant attention. The e-commerce company Rent the Runway saw shares soar over the week. The energy company Constellation Energy Corp. Saw shares trading near all-time highs. Chipotle Mexican Grill is set to report its quarterly results on April 24.
Benzinga · 17h ago
QUAL, NKE, JNJ, GOOG: Large Inflows Detected at ETF
NASDAQ · 18h ago
RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up
NASDAQ · 18h ago
Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
NASDAQ · 19h ago
J&J (JNJ) to Begin Pharma Q1 Earnings Season: What's in Store?
NASDAQ · 20h ago
Johnson & Johnson: Doubling Down On This 2024 Dog Of The Dow
Johnson & Johnson (JNJ) is included in the Dogs of the Dow list for 2024. The company is positioned to gain on the upside due to solid financials and a potential increase in healthcare spending. The dividend has been increased for over 61 consecutive years. The current dividend yield is over 3% and JNJ is one of the most reliable dividend stocks in history.
Seeking Alpha · 21h ago
5 Dividend Kings That Yield More Than Vanguard's Top Value ETF
The Vanguard Value ETF has a 2.4% yield, but some Dividend Kings pay more than that. Coca-Cola, PepsiCo, Johnson & Johnson, and Stanley Black & Decker are four companies that all yield over 3%. Target is a good buy with a 3.6% yield.
The Motley Fool · 21h ago
Healthpeak Properties: A Quality Healthcare REIT That Should Get Back To Dividend Growth
Seeking Alpha · 22h ago
U.S. Wide-Moat Stocks On Sale - The April 2024 Heat Map
As of April 11, there were 158 U.S. Wide-moat stocks meeting Morningstar's criteria. Only 4.4% of these stocks earned a 5-star valuation rating. The heat map of the most investable candidates lists the best companies on sale. We focus on the most attractively valued stocks with a wide- moat rating.
Seeking Alpha · 1d ago
Health Care Sector Update for 04/11/2024: ENLV, RLYB, JNJ, UNH, ELYM
NASDAQ · 1d ago
Notable Thursday Option Activity: THO, DOCU, JNJ
NASDAQ · 1d ago
10 Attractive sell puts within the Russell 1000 - JPM
10 Attractive sell puts within the Russell 1000 - JPMorgan analysts published a list of put underwriting opportunities within theRussell 1000 universe of single stocks with a liquid option market. The put selling signal would be triggered if the buy signals are greater than the sell signals. Johnson & Johnson is one of the 10 attractive three-month sell puts underwriting candidates.
Seeking Alpha · 1d ago
May 31st Options Now Available For Johnson & Johnson (JNJ)
NASDAQ · 1d ago
Kenvue's performance has been 'woeful' with 'worst-in-class' growth - analyst
Consumer Kenvue's performance has been 'woeful' with 'worst-in-class' growth - analyst Bernstein. Bernstein set its price target for Ken vue at $18, 12% below Wednesday's closing price. The company's growth is the 'worst in the class' among competitors.
Seeking Alpha · 1d ago
5 Things To Know In Investing This Week - The Shockwave Takeover Issue
Shockwave Medical was in takeover talks with Johnson & Johnson. The company agreed to pay $335 per share in cash for Shockwave Medical. The purchasing managers index (PMI) came in hot this week. The CBO releases projections of the US debt to GDP are lies. DKI subscribers celebrated as the index came in high.
Benzinga · 1d ago
More
Webull provides a variety of real-time JNJ stock news. You can receive the latest news about Johnson & Johnson through multiple platforms. This information may help you make smarter investment decisions.
About JNJ
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, and vision fields. These products are distributed to wholesalers, hospitals, and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.